Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL. | Hemasphere | 2023 | 37731707 | PubTator, text mining | PubMed |
| Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy. | Front Oncol | 2023 | 37719021 | PubTator, text mining | PubMed |
| Identification of prognostic immune subtypes of lung squamous cell carcinoma by unsupervised consistent clustering. | Medicine (Baltimore) | 2023 | 37713826 | PubTator, text mining | PubMed |
| Nucleosome repositioning in chronic lymphocytic leukemia. | Genome Res | 2023 | 37699659 | PubTator, text mining | PubMed |
| Zanubrutinib: past, present, and future. | Blood Cancer J | 2023 | 37696810 | PubTator, text mining | PubMed |
| Next-Generation Sequencing-Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL). | Curr Oncol Rep | 2023 | 37682487 | PubTator, text mining | PubMed |
| Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis. | Leuk Res Rep | 2023 | 37680324 | PubTator, text mining | PubMed |
| Impending splenic rupture as indicator of atypical chronic lymphocytic leukemia: A case report from Saudi Arabia. | Int J Surg Case Rep | 2023 | 37678031 | PubTator, text mining | PubMed |
| A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia. | iScience | 2023 | 37664638 | PubTator, text mining | PubMed |
| Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines. | Front Endocrinol (Lausanne) | 2023 | 37654571 | PubTator, text mining | PubMed |
Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | 37651309 | PubTator, text mining | PubMed |
| Engaging an HIV vaccine target through the acquisition of low B cell affinity. | Nat Commun | 2023 | 37640732 | PubTator, text mining | PubMed |
| Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia. | Int J Hematol Oncol Stem Cell Res | 2023 | 37638287 | PubTator, text mining | PubMed |
| Acalabrutinib and steroid for autoimmune thrombocytopenia due to relapsed chronic lymphocytic leukemia with severe bone marrow infiltration. | J Clin Exp Hematop | 2023 | 37635085 | PubTator, text mining | PubMed |
| A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting. | Medicina (Kaunas) | 2023 | 37629695 | PubTator, text mining | PubMed |
| Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study. | Cancers (Basel) | 2023 | 37627075 | PubTator, text mining | PubMed |
| Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents. | J Hematol Oncol | 2023 | 37626420 | PubTator, text mining | PubMed |
| Editorial: The promise of immunogenetics for precision oncology. | Front Oncol | 2023 | 37621683 | PubTator, text mining | PubMed |
| How I Manage Chronic Lymphocytic Leukemia. | Hematol Rep | 2023 | 37606492 | PubTator, text mining | PubMed |
| Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up. | Blood | 2023 | 37595283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=14